Therefore, we detected expression levels of THOP1 protein in patients with NSCLC by employing immunohistochemical method to investigate its correlation with clinicopathologic features, postoperative tumor relapse and prognosis. This evidence concerns the gene THOP1 and non-small cell lung carcinoma.